Arcadio Garcia de Castro

Arcadio Garcia de Castro is an experienced professional with a diverse background in biotechnology and pharmaceutical development. Currently serving as an External Professor at the University of Navarra since September 2024, Arcadio also holds the position of Director and Founder at HELICON MEDICAL, focusing on early-stage pharmaceutical formulation and drug delivery. Since September 2017, Arcadio has contributed as Chief Scientific Officer at Stablepharma Limited, overseeing vaccine research and development. Previous roles include being a Board Member and Founder of QUBE, Technical Director at VB Devices, and Director at AzureBio S.L. Among earlier positions, Arcadio has held significant roles at Chimera Pharma SLU, PharmaMar, and Cambridge Biostability, contributing to innovative vaccine development and business growth. Arcadio's academic credentials include a Bachelor's degree in Microbiology, a PhD in Cell Culture Bioreactors, and post-doctoral studies in Biotechnology at the University of Cambridge.